National Alliance for Autism Research

The National Alliance for Autism Research (NAAR), based in Princeton, New Jersey, was a non-profit advocacy organization, founded by parents of children with autism concerned about the limited funding available for research.

Origins and activities
NAAR was founded in 1994 as an attempt to stimulate biomedical research and science-based approaches to understanding, treating, and curing autism spectrum disorders. The founders comprised a small group of parents, including two psychiatrists, a lawyer and a chemistry professor.

NAAR raised money to provide research grants focusing on autism, and has committed an excess of $20 million to over 200 autism research projects, fellowships and collaborative programs - more than any other non-governmental organization. NAAR focused intently on its role in establishing and funding the Autism Tissue Program, a post-mortem brain tissue donation program designed to further autism research studies at the cellular and molecular level. Other major programs included the 'High Risk Baby Sibling Autism Research Project', and the 'NAAR Genome Project'. NAAR also published the NAARRATIVE, a newsletter on autism biomedical research. In early 2006, NAAR merged with Autism Speaks.

Controversies
NAAR helped fund a Danish epidemiological study, along with the Centers for Disease Control (CDC), which concluded no link could be found between MMR vaccines and increases in reported cases of autism. Detractors contended the study was flawed and was compromised by conflict of interest problems.